JP2023546584A5 - - Google Patents
Info
- Publication number
- JP2023546584A5 JP2023546584A5 JP2023524127A JP2023524127A JP2023546584A5 JP 2023546584 A5 JP2023546584 A5 JP 2023546584A5 JP 2023524127 A JP2023524127 A JP 2023524127A JP 2023524127 A JP2023524127 A JP 2023524127A JP 2023546584 A5 JP2023546584 A5 JP 2023546584A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- salt
- halo
- alkyl
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063104933P | 2020-10-23 | 2020-10-23 | |
| US63/104,933 | 2020-10-23 | ||
| PCT/US2021/056003 WO2022087234A1 (en) | 2020-10-23 | 2021-10-21 | Anticancer compounds selective for er-positive cancers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023546584A JP2023546584A (ja) | 2023-11-06 |
| JP2023546584A5 true JP2023546584A5 (enExample) | 2024-10-25 |
Family
ID=81290080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023524127A Pending JP2023546584A (ja) | 2020-10-23 | 2021-10-21 | Ｅｒ陽性がんに選択的な抗がん化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12655104B2 (enExample) |
| EP (1) | EP4232038A4 (enExample) |
| JP (1) | JP2023546584A (enExample) |
| CN (1) | CN116723841A (enExample) |
| AU (2) | AU2021366688B2 (enExample) |
| CA (1) | CA3196210A1 (enExample) |
| IL (1) | IL302154A (enExample) |
| MX (1) | MX2023004480A (enExample) |
| WO (1) | WO2022087234A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN120981469A (zh) * | 2023-02-23 | 2025-11-18 | 晨晖生物科技(香港)有限公司 | 含硼化合物及其治疗用途 |
| WO2026039467A1 (en) * | 2024-08-12 | 2026-02-19 | The Board Of Trustees Of The University Of Illinois | Hydroxyphenyl-indoline-2-one cancer therapeutics |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2855406A (en) | 1955-05-07 | 1958-10-07 | Dann Otto | Preparation of benzopyrans and benzofurans |
| US3773759A (en) | 1972-08-21 | 1973-11-20 | Searle & Co | 1-arylideneamino-4-(2-oxo-3-phenyl-3-benzofuryl)piperazines |
| FR2810320B1 (fr) | 2000-06-19 | 2002-08-23 | Sanofi Synthelabo | Nouveaux derives de 1,3-dihydro-2h-indol-2-one, un procede pour leur preparation et les compositions pharmaceutiques en contenant |
| CA2684552A1 (en) * | 2007-04-24 | 2008-10-30 | Topotarget A/S | Substituted 3-(4-hydroxyphenyl)-indolin-2-one compounds |
| EA027139B1 (ru) | 2013-04-26 | 2017-06-30 | Бейджин, Лтд. | Замещенные 5-(3,5-диметилизоксазол-4-ил)индолин-2-оны |
| CN108440378B (zh) | 2018-03-27 | 2021-03-12 | 宁波大学 | 一种室温下碘-双氧水促进的3-氨基-2-吲哚酮衍生物的制备方法 |
| EP3817741A4 (en) * | 2018-07-03 | 2022-07-06 | The Board of Trustees of the University of Illinois | ACTIVATORS OF THE UNFOLDING PROTEIN RESPONSE |
-
2021
- 2021-10-21 WO PCT/US2021/056003 patent/WO2022087234A1/en not_active Ceased
- 2021-10-21 CA CA3196210A patent/CA3196210A1/en active Pending
- 2021-10-21 US US18/033,173 patent/US12655104B2/en active Active
- 2021-10-21 CN CN202180086814.XA patent/CN116723841A/zh active Pending
- 2021-10-21 EP EP21883881.1A patent/EP4232038A4/en active Pending
- 2021-10-21 IL IL302154A patent/IL302154A/en unknown
- 2021-10-21 MX MX2023004480A patent/MX2023004480A/es unknown
- 2021-10-21 JP JP2023524127A patent/JP2023546584A/ja active Pending
- 2021-10-21 AU AU2021366688A patent/AU2021366688B2/en active Active
-
2026
- 2026-06-02 AU AU2026204244A patent/AU2026204244A1/en active Pending